AMPAC expands its activities in Petersburg and adds 156 jobs


Pharmaceutical maker plans to invest $ 25 million


May 4, 2021


Kate andrews

AMPAC Fine Chemicals plans to expand its manufacturing facility in Petersburg, investing $ 25 million and creating 156 jobs, Governor Ralph Northam said on Tuesday.

AMPAC manufactures active pharmaceutical ingredients (APIs) and is a partner of Richmond-based Phlow Corp., the Medicines for All Institute at Virginia Commonwealth University, and non-profit drug maker Civica Inc., as part of a federally funded $ 354 million contract to reduce the United States’ reliance on foreign supply chains. and producing domestic production sources for drugs and pharmaceutical ingredients at risk of shortage, including treatments for COVID-19.

Phlow was awarded the four-year contract from the US Biomedical Advanced Research and Development Authority (BARDA) in May 2020. In January, Utah-based Civica Inc. announced it would establish its North American manufacturing facility. in Petersburg, investing $ 124.5 million to establish a new facility alongside the future operation of Phlow and the existing facility of AMPAC. With Tuesday’s announcement, AMPAC will expand its current plant, which it moved to in 2019. The Civica plant will convert the active pharmaceutical ingredients produced by AMPAC and Phlow into vials and syringes for use in hospitals.

“AMPAC’s investment will further advance the pharmaceutical cluster that has emerged in Petersburg and consolidate our Commonwealth as an important player in the manufacture of domestic medicines,” Northam said in a statement. “This vital partnership between Phlow Corp., Medicines for All Institute, Civica Inc. and AMPAC will have a far-reaching and positive impact, ensuring better access to high-quality life-saving medicines while creating jobs needed to support our economy. recovery in Virginia. “

AMPAC was founded in 1945 and currently employs 109 people in Virginia, which competed for the project against California and Texas, where AMPAC has two other operations.

“At our three AMPAC sites, Virginia provides an enabling environment to develop and sustain the growth of the capabilities and infrastructure required for the pharmaceutical industry,” said William DuBay, global vice president of research and development at AMPAC, in a press release. “Our growing relationship with the Commonwealth, [the Virginia Economic Development Partnership], the City of Petersburg and others, including VCU, Phlow and Civica, is the cornerstone of our vision for the US manufacture of critical pharmaceutical ingredients.

VEDP worked with the City of Petersburg, the Gateway Area in Virginia, the Community College Workforce Alliance, and Dominion Energy Inc. to secure the project, and Northam approved a $ 640,000 Opportunity Fund grant and a $ 640,000 Opportunity Fund grant. $ 250,000 for investment performance in Virginia. VEDP’s Virginia Talent Accelerator program will provide training and recruitment to AMPAC at no cost to the company.

Leave A Reply

Your email address will not be published.